Navigation Links
Prime Therapeutics Announces URAC Accreditation
Date:10/3/2007

Prime earns first-ever accreditation for pharmacy benefit management

organizations

ST. PAUL, Minn., Oct. 3 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has achieved URAC Pharmacy Benefit Management (PBM) accreditation.

The URAC PBM accreditation program is designed to encourage PBM industry best practices, promote quality improvement and protect and empower consumers. Prime began its participation with URAC's beta testing process in June 2007. Prime is now URAC accredited. "Prime has worked hard for this achievement. We strive to improve and promote standard practices in the PBM industry," said Prime's Chief Medical Officer and Senior Vice President, Dr. James Hartert. "Prime believes in continuous improvement in the quality of services we provide to our clients and their members. URAC's accreditation is further proof that Prime lives by its business model of providing the highest quality of services, while ensuring efficiency in cost management."

The URAC standards development process is consensus driven, with hundreds of industry experts serving as volunteers to establish and revise appropriate industry benchmarks. "By applying for and receiving URAC accreditation, Prime Therapeutics has demonstrated a commitment to quality health care," said Alan P. Spielman, URAC's President and CEO. "Quality health care is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards."

URAC's standards address a range of industry practices including: organizational quality, customer service/communications/disclosure, pharmacy distribution channels, formulary/pharmacy and therapeutics, and drug utilization management.

Prime Therapeutics LLC is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions
'/>"/>

SOURCE Prime Therapeutics LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Indian Prime Minister has successful Knee Replacement Surgery
2. Aggressiveness is a prime heart disease risk
3. Prime Minister Manmohan Against Incentive-Based Population Control
4. Prime Minister Declares War on AIDS
5. Indian Prime Minister undergoes Minor Surgery in AIIMS
6. Movie Smoking Is The Prime Triggering Factor For Adolescents
7. Plastic Surgery Is Primetime among Ethnic Groups
8. Prime Suspect Apprehended in AIIMS Question Paper Leak
9. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
10. Prime Minister Asks Medicos to End Strike
11. Prime Minister Reassure Medical Students Asks them to Call off Strike
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)... HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCa...oard: CSKI), a manufacturer, marketer and,distribu...oducts in China,today announced that it will cond... May 15, 2008 to discuss its first quarter 2008 fi...man, CEO and Director of China Sky One,Medical, In...
(Date:5/13/2008)...ildbearing had no such benefit if baby was bottle-...13 (HealthDay News) -- Women who breast feed for m...arthritis (RA) by half, according to a new Swedish...g children but not breast-feeding offered women no...contraceptives also failed to reduce the risk of R...
(Date:5/13/2008)...NEW YORK (May 13, 2008) -- Promising results from ...ell Medical Center physician-scientists show that ... the progression of Batten disease, or Late Infant..., genetic, degenerative neurological disorder that... to 12. , The clinical trial found that the pro...
(Date:5/13/2008)... SALT LAKE CITY, May 13 /PRNewswire/ -- Paramed S...ent of their marine-grade Mobility Offers,Versatil...chair to oil and,gas platform operators in the Gul...platforms will enable the safe and timely evacuati...atform., Paramed developed the dual-track MOV in ...
Breaking Medicine News(10 mins):Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Breast-feeding Might Shield Women From Rheumatoid Arthritis 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2
... tortillas probably doesn't come to mind. But a Ka...with ways to add fiber to the foods we love witho.... Sajid Alavi is an assistant professor of grain ...ollege of Agriculture. His expertise is in extrusi...
...otting protein found in circulating blood, has bee...ystem neuronal cells , a process that is necessary...umatic injury. The findings by researchers at the...CSD) School of Medicine, may explain why the human...
...12 weeks pregnant with rocker boyfriend Joel Madde...fe" star, is reported to have shared the joyful ne...cluding Mischa Barton. However, she is neither co...r pregnancy to the media. Apart from her impendin...
...covered from the bottom of a two-kilometre thick i...s much warmer at some point during the last Ice Ag...e trees, plants and insects of a boreal forest est...,000 years old. Previously, the youngest evidence ...
Other Medicine News:Health News:Snack Foods Fortified With Fiber 2Health News:Fibrinogen may Inhibit Spinal Cord Regeneration 2
(Date:5/12/2008)... their function like a radio dial, not an on/off,l...une disease may develop,late in life, MEMPHIS, ...e Children,s,Research Hospital study shows that T ... use simple on/off switches to govern the cellular...nction. Rather, they,possess sophisticated molecul...
(Date:5/12/2008)... 12 /- Arbios Systems, Inc....he Company has received,approval from the U.S. Foo...ional Device Exemption ("IDE") to begin the pivota...real (outside the body) liver assist,device for bl... from,chronic liver disease., "We are pleased to ...
(Date:5/12/2008)...rt 3 Demonstrated Improvement in T-Cell Responses ...al of HspE7, SAN DIEGO, May 12 /PRNewswire-FirstC...: NVN) today announced positive immunological data...ical trial of its lead product,candidate, HspE7, i..., or,CIN, a precursor to cervical cancer. HPV 16 E...
(Date:5/9/2008).../PRNewswire-USNewswire/ -- Many strong acting pain...an include nausea and,vomiting with short-term use...symptoms can lead patients to discontinue treatmen...ent for physicians. The novel investigational,medi...ic, provided pain,relief for patients with fewer g...
Breaking Medicine Technology:St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 2Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 3Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 4Arbios Receives Approval From the FDA to Initiate Pivotal Trial for SEPET(TM) Liver Assist Device 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4Registry unveils real world data on novel excel stent 15505 1Registry unveils real world data on novel excel stent 15505 2Study finds support for PCI in unprotected left main disease 15501 1Study finds support for PCI in unprotected left main disease 15501 2Study finds support for PCI in unprotected left main disease 15501 3Response Biomedical Corporation Reports 2007 Financial Results 15498 1Response Biomedical Corporation Reports 2007 Financial Results 15498 2Response Biomedical Corporation Reports 2007 Financial Results 15498 3Response Biomedical Corporation Reports 2007 Financial Results 15498 4Response Biomedical Corporation Reports 2007 Financial Results 15498 5China Medicine Corporation to Present at Brean Murray Carret 26 Co Mainland China Investor Tour 15494 1China Medicine Corporation to Present at Brean Murray Carret 26 Co Mainland China Investor Tour 15494 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: